Scalable Cell Transfection Technology From Concept To Manufacturing
Source: MaxCyte, Inc.
In this presentation, experts dive into the details of cell transfection technology, efficient gene knock-ins with mbDNA, homology-independent targeted insertion for clinical-scale CAR T Manufacturing, and organoid engineering. Large strides are being made in gene editing that can be credited to electroporation and CRISPR technology. Explore clinical trials and case study results focused on gene editing, as well as platforms that allow you to successfully scale up your production and improve your T Cell manufacturing.
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
MaxCyte, Inc.
This website uses cookies to ensure you get the best experience on our website. Learn more